These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 28338954)

  • 1. Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.
    Wang AK; Miller BJ
    Schizophr Bull; 2018 Jan; 44(1):75-83. PubMed ID: 28338954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hidese S; Hattori K; Sasayama D; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Noda T; Yoshida S; Teraishi T; Hori H; Ota M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():12-18. PubMed ID: 28238731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia.
    Ishii T; Hattori K; Miyakawa T; Watanabe K; Hidese S; Sasayama D; Ota M; Teraishi T; Hori H; Yoshida S; Nunomura A; Nakagome K; Kunugi H
    Biochem Biophys Res Commun; 2018 Mar; 497(2):683-688. PubMed ID: 29454970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects.
    Hidese S
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):314-320. PubMed ID: 38686540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
    Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landén M; Hultman CM; Erhardt S
    Psychiatry Res; 2017 Jan; 247():105-112. PubMed ID: 27886578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
    Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis.
    Gallego JA; Blanco EA; Husain-Krautter S; Madeline Fagen E; Moreno-Merino P; Del Ojo-Jiménez JA; Ahmed A; Rothstein TL; Lencz T; Malhotra AK
    Schizophr Res; 2018 Dec; 202():64-71. PubMed ID: 30025760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia.
    Brum M; Nieberler M; Kehrwald C; Knopf K; Brunkhorst-Kanaan N; Etyemez S; Allers KA; Bittner RA; Slattery DA; McNeill RV; Reif A; Kittel-Schneider S
    World J Biol Psychiatry; 2023; 24(7):564-577. PubMed ID: 36648064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies.
    Marx W; McGuinness AJ; Rocks T; Ruusunen A; Cleminson J; Walker AJ; Gomes-da-Costa S; Lane M; Sanches M; Diaz AP; Tseng PT; Lin PY; Berk M; Clarke G; O'Neil A; Jacka F; Stubbs B; Carvalho AF; Quevedo J; Soares JC; Fernandes BS
    Mol Psychiatry; 2021 Aug; 26(8):4158-4178. PubMed ID: 33230205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
    Enache D; Pariante CM; Mondelli V
    Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
    Pearlman DM; Najjar S
    Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.
    Kageyama Y; Kasahara T; Kato M; Sakai S; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Goto Y; Kinoshita T; Inoue K; Kato T
    J Affect Disord; 2018 Jun; 233():15-20. PubMed ID: 28633757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study.
    Hidese S; Hattori K; Sasayama D; Tsumagari T; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Yoshida S; Ota M; Kunugi H
    Front Pharmacol; 2020; 11():594394. PubMed ID: 33708113
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.
    Regenold WT; Phatak P; Marano CM; Sassan A; Conley RR; Kling MA
    Biol Psychiatry; 2009 Mar; 65(6):489-94. PubMed ID: 19103439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking nervous and immune systems in psychiatric illness: A meta-analysis of the kynurenine pathway.
    Sales PMG; Schrage E; Coico R; Pato M
    Brain Res; 2023 Feb; 1800():148190. PubMed ID: 36463958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis.
    Zhang Y; Wang J; Ye Y; Zou Y; Chen W; Wang Z; Zou Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jul; 125():110740. PubMed ID: 36893912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia.
    Mizui T; Hattori K; Ishiwata S; Hidese S; Yoshida S; Kunugi H; Kojima M
    J Psychiatr Res; 2019 Jun; 113():190-198. PubMed ID: 30986693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis.
    Hebbrecht K; Skorobogatov K; Giltay EJ; Coppens V; De Picker L; Morrens M
    Front Immunol; 2021; 12():667179. PubMed ID: 34093561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.
    Schwieler L; Larsson MK; Skogh E; Kegel ME; Orhan F; Abdelmoaty S; Finn A; Bhat M; Samuelsson M; Lundberg K; Dahl ML; Sellgren C; Schuppe-Koistinen I; Svensson C; Erhardt S; Engberg G
    J Psychiatry Neurosci; 2015 Mar; 40(2):126-33. PubMed ID: 25455350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.